The new piericidin group antibiotics, glucopiericidins A and B were isolated from the culture broth of Streptomyces pactum S48727 (FERMP-8117) as co-metabolite of piericidin Ai.
The structures of glucopiericidins A and B were determined as piericidin Al9 10-O-fi-Dglucoside and piericidin Al9 3'-0-D-glucoside on the basis of their spectral and chemical properties , respectively.
Glucopiericidins were more potent in inhibiting antibody formation than piericidin Ai in vitro. In addition, these substances showedbetter antimicrobial activities than piericidin AÂ cute toxicities of these substances in mice were lower than that of piericidin Ax. This indicates that D-glucose in glucopiericidin molecules is important in modulating their physiological activities.
In the course of a screening for physiologically active substances, a strain of actinomycetes, S48727, was shown to produce new piericidin glucosides, glucopiericidins A and B in addition to the known antibiotic piericidin A^K They showed antimicrobial activity and in vitro inhibitory activity against antibody formation. This paper reports the taxomony of the producing organism and the fermentation, the isolation, structures and biological properties of glucopiericidins A and B.
Taxonomy Strain S48727 was isolated from a soil sample collected at Futaba-gun, Fukushima Prefecture, Japan.
The organism was identified as a strain of Streptomyces pactum*'^. It has the fundamental characteristics of the organism, namely, mature aerial mass color is in the gray color series on most media. Nocharacteristic color is observed in reverse side of colony commonly used in taxonomic studies6) ( Table 1) .
The sporophores are Spiral type and have morethan ten spores per chain. The spores with hairy surface are cylindical or oval, 0.5~0.8 x0.7~1.4 //m. Wholecell hydrolysates of strain S48727 showed that it contained LL-diaminopimelic acid.
Melanoid pigment are not formed in peptone -yeast extract -iron agar, tyrosine agar and Tryptone -yeast extract broth (Table 2) . No soluble pigment is produced. D-Glucose and rafrlnose are utilized for growth (Table 3) .
This strain also produced piericidin Als but not other piericidins such as piericidins Bi and Q.
Ferment ati o n A loopful of strain S48727 on agar slant was inoculated into a 500-ml Sakaguchi flask containing 120 rpm, and 2ml of the growth was transferred to 500-ml Sakaguchi flask containing 100 ml of production medium (Table 4 ). The fermentation was carried out for 70~100 hours under the same conditions described above. Though glucose is only carbon source, it is hardly consumed, and mycelium increased slightly.
Glucopiericidin A is produced after piericidin Ax as shown in Fig. 1 . This indicates that piericidin A1 has been converted to glucopiericidin A by glucosylation. The sample for HPLCwas prepared after 96 hours incubation by ethyl acetate extract. Glucopiericidin A is a main product, whereas piericidin A1 and glucopiericidin B are minor products as shown in Fig. 2 . Isolation Most of the antibiotics was found in the broth filtrate extract.
After fermentation was completed, the culture broth (10 liters) was centrifuged. The collected cake was extracted twice with 2 liters of methanol. The methanol extract was concentrated in vacuo and remaining aqueous solution was extracted twice with 2 liters of ethyl acetate.
The broth filtrate was extracted twice with 15 liters of ethyl acetate. The ethyl acetate extracts from cake and filtrate were combined and concentrated in vacuo to an oily residue. After washing with /z-hexane, the oily residue was chromatographed on a silica gel column (3.0 x45 cm) with chloroform -methanol (98: 2, 96: 4). Piericidin Ax fractions eluted before glucopiericidins A and B. Glucopiericidin A fractions were concentrated in vacuo to dryness, dissolved in a small amount Table 5 . They are amorphous powders. Though glucopiericidin A is weakly acidic, glucopiericidin B is neutral. They are soluble in methanol, ethyl acetate, acetone and chloroform, and insoluble in nhexane and water.
The same molecular formula C31H47O9Nwas determined from the mass spectra (m/z 578, (M +H)+) and elemental analyses of glucopiericidins A and B. They were hydrolyzed by 5 n HC1 at 60°C for 30 minutes and analyzed with GC. D-Glucose was found in both compounds.
The structural determination of glucopiericidins A and B was performed by comparing the JH and 13C NMRspectra with those of piericidin Ax. The XHNMRspectra of glucopiericidins A and B are shown in Fig. 3 . The XHNMRspectrum of glucopiericidin A shows one characteristic anomeric proton as a doublet at 8 4.13 (/=7.3 Hz), whereas that of glucopiericidin B shows one anomeric proton as a broad signal near <5 4.8. This indicates that D-glucose is linked by a /3-configulation in glucopiericidin A. But, it is vague in glucopiericidin B whether the configuration of D-glucose is an a or^-linkage. Assignments of 13C NMRspectra of piericidin Al9 glucopiericidins A and B are shown in Table 6 Fig. 4 , respectively.
Biological Properties The effects of piericidin Al3 glucopiericidins A and B on antibody formation to sheep red blood cells (SRBC) in mouse spleen cell cultures were examined by the procedure of Mishell & Dutton7) . At the same time, the effects of these substances to LSI78Yleukemia cells were examinedas a marker of cytotoxicity.
Spleen cells from CDFXmouse in cold Hanks' balanced salts solution (HBSS) were washed and suspended to 1.5 x lO7 cells/ml in RPMI-1640 supplemented with sodium pyruvate, non-essential amino acids, glutamine and 10%fetal calf serum. In a 24-well micro-test-plate, the spleen cell suspension (0.5 ml) was added 0.75 x 106 cells of SRBCas the antigen and incubated in humidified 5% CO2-95%air at 37°C. Each substance was added at the initiation of the culture. After 4 days, antibody formation was measured by counting plaque forming cells (PFC). L5178Y cells (4 x lO4) were incubated with each substance in 200 [A of RPMI-1640 supplemented with 10% fetal calf serum at 37°C in humidified 5% CO2-95%air and the cell number was counted by a Coulter counter after 48 hours incubation. The results are shown in Fig. 5 . In piericidin Al9 antibody formation is weakly suppressed among 20~30% at the concentration of lO'^lO"1 jug/ml, whereas no effect is observed on cytotoxicjty at the same concentration. Antibody formation is totally inhibited at the concentration of 10"4^g/ml of glucopiericidin A, whereas no effect is observed on cytotoxicity at the concentration of 10~51 0"* jug/ml as same as piericidin A±. Glucopiericidin B totally inhibited antibody formation at the concentration of 10"5^g/ml, whereas dose related cytotoxicity was observed. The separation of inhibition of antibody formation and the cytotoxicity by glucopiericidins clearly indicate that the two effect are not related. D-Glucose in glucopiericidins molecule seemed to be necessary for inhibitory activity since piericidin Ax was less effective than the glucosylated substances in tests.
The antimicrobial spectra of glucopiericidins were determined by the agar dilution method. As shown in Table 7 , glucopiericidin A inhibits the growth of Gram-positive bacteria and Piricularia oryzae, whereas glucopiericidin B is more active than glucopiericidin A against those of strains and inhibits the growth of fungi, more ever. Glucopiericidins in general are more active antimicrobial agents than piericidin Ax.
The acute toxicity of glucopiericidins A and B was determined in mice. An intravenous dosage of 30 mg/kg or more sacrificed all the mice, but at 10 mg/kg all survived. Then, in piericidin Al9 an intravenous dosage of 1.0 mg/kg or more sacrificed all the mice.
